ID   KPCE_HUMAN              Reviewed;         737 AA.
AC   Q02156; B0LPH7; Q32MQ3; Q53SL4; Q53SM5; Q9UE81;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1993, sequence version 1.
DT   10-MAY-2017, entry version 179.
DE   RecName: Full=Protein kinase C epsilon type;
DE            EC=2.7.11.13;
DE   AltName: Full=nPKC-epsilon;
GN   Name=PRKCE; Synonyms=PKCE;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1382605; DOI=10.1016/0167-4781(92)90006-L;
RA   Basta P., Strickland M.B., Holmes W., Loomis C.R., Ballas L.M.,
RA   Burns D.J.;
RT   "Sequence and expression of human protein kinase C-epsilon.";
RL   Biochim. Biophys. Acta 1132:154-160(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   SeattleSNPs variation discovery resource;
RL   Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION IN PHOSPHORYLATION OF KRT8.
RX   PubMed=1374067; DOI=10.1083/jcb.117.3.583;
RA   Omary M.B., Baxter G.T., Chou C.F., Riopel C.L., Lin W.Y.,
RA   Strulovici B.;
RT   "PKC epsilon-related kinase associates with and phosphorylates
RT   cytokeratin 8 and 18.";
RL   J. Cell Biol. 117:583-593(1992).
RN   [7]
RP   PHOSPHORYLATION AT THR-566 AND SER-729, AND MUTAGENESIS OF LYS-437;
RP   THR-566; THR-710 AND SER-729.
RX   PubMed=11964154; DOI=10.1042/0264-6021:3630537;
RA   Cenni V., Doeppler H., Sonnenburg E.D., Maraldi N., Newton A.C.,
RA   Toker A.;
RT   "Regulation of novel protein kinase C epsilon by phosphorylation.";
RL   Biochem. J. 363:537-545(2002).
RN   [8]
RP   FUNCTION IN PHOSPHORYLATION OF TRPV1.
RX   PubMed=11884385; DOI=10.1074/jbc.C200104200;
RA   Numazaki M., Tominaga T., Toyooka H., Tominaga M.;
RT   "Direct phosphorylation of capsaicin receptor VR1 by protein kinase
RT   Cepsilon and identification of two target serine residues.";
RL   J. Biol. Chem. 277:13375-13378(2002).
RN   [9]
RP   FUNCTION IN PHOSPHORYLATION OF IQGAP1.
RX   PubMed=15355962; DOI=10.1074/jbc.M408113200;
RA   Grohmanova K., Schlaepfer D., Hess D., Gutierrez P., Beck M.,
RA   Kroschewski R.;
RT   "Phosphorylation of IQGAP1 modulates its binding to Cdc42, revealing a
RT   new type of rho-GTPase regulator.";
RL   J. Biol. Chem. 279:48495-48504(2004).
RN   [10]
RP   INTERACTION WITH DGKQ.
RX   PubMed=15632189; DOI=10.1074/jbc.M409301200;
RA   van Baal J., de Widt J., Divecha N., van Blitterswijk W.J.;
RT   "Translocation of diacylglycerol kinase theta from cytosol to plasma
RT   membrane in response to activation of G protein-coupled receptors and
RT   protein kinase C.";
RL   J. Biol. Chem. 280:9870-9878(2005).
RN   [11]
RP   FUNCTION.
RX   PubMed=16757566; DOI=10.1073/pnas.0600462103;
RA   McGettrick A.F., Brint E.K., Palsson-McDermott E.M., Rowe D.C.,
RA   Golenbock D.T., Gay N.J., Fitzgerald K.A., O'Neill L.A.J.;
RT   "Trif-related adapter molecule is phosphorylated by PKCepsilon during
RT   Toll-like receptor 4 signaling.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:9196-9201(2006).
RN   [12]
RP   FUNCTION IN PHOSPHORYLATION OF STAT3, AND INTERACTION WITH STAT3.
RX   PubMed=17875724; DOI=10.1158/0008-5472.CAN-07-1604;
RA   Aziz M.H., Manoharan H.T., Church D.R., Dreckschmidt N.E., Zhong W.,
RA   Oberley T.D., Wilding G., Verma A.K.;
RT   "Protein kinase Cepsilon interacts with signal transducers and
RT   activators of transcription 3 (Stat3), phosphorylates Stat3Ser727, and
RT   regulates its constitutive activation in prostate cancer.";
RL   Cancer Res. 67:8828-8838(2007).
RN   [13]
RP   FUNCTION IN CELL MOTILITY, AND SUBCELLULAR LOCATION.
RX   PubMed=17603037; DOI=10.1016/j.exer.2007.05.004;
RA   Sharma G.D., Kakazu A., Bazan H.E.;
RT   "Protein kinase C alpha and epsilon differentially modulate hepatocyte
RT   growth factor-induced epithelial proliferation and migration.";
RL   Exp. Eye Res. 85:289-297(2007).
RN   [14]
RP   FUNCTION IN PHOSPHORYLATION OF GABRG2.
RX   PubMed=17875639; DOI=10.1074/jbc.M707233200;
RA   Qi Z.H., Song M., Wallace M.J., Wang D., Newton P.M., McMahon T.,
RA   Chou W.H., Zhang C., Shokat K.M., Messing R.O.;
RT   "Protein kinase C epsilon regulates gamma-aminobutyrate type A
RT   receptor sensitivity to ethanol and benzodiazepines through
RT   phosphorylation of gamma2 subunits.";
RL   J. Biol. Chem. 282:33052-33063(2007).
RN   [15]
RP   REVIEW ON FUNCTION.
RX   PubMed=12473185; DOI=10.1093/oxfordjournals.jbchem.a003296;
RA   Akita Y.;
RT   "Protein kinase C-epsilon (PKC-epsilon): its unique structure and
RT   function.";
RL   J. Biochem. 132:847-852(2002).
RN   [16]
RP   REVIEW ON FUNCTION IN APOPTOSIS.
RX   PubMed=16584980;
RA   Vitale M., Gobbi G., Mirandola P., Ponti C., Sponzilli I., Rinaldi L.,
RA   Manzoli F.A.;
RT   "TNF-related apoptosis-inducing ligand (TRAIL) and erythropoiesis: a
RT   role for PKC epsilon.";
RL   Eur. J. Histochem. 50:15-18(2006).
RN   [17]
RP   REVIEW ON FUNCTION IN NEURONS.
RX   PubMed=18637121; DOI=10.1111/j.1742-4658.2008.06556.x;
RA   Shirai Y., Adachi N., Saito N.;
RT   "Protein kinase Cepsilon: function in neurons.";
RL   FEBS J. 275:3988-3994(2008).
RN   [18]
RP   REVIEW ON FUNCTION IN CYTOSKELETON.
RX   PubMed=18637120; DOI=10.1111/j.1742-4658.2008.06557.x;
RA   Akita Y.;
RT   "Protein kinase Cepsilon: multiple roles in the function of, and
RT   signaling mediated by, the cytoskeleton.";
RL   FEBS J. 275:3995-4004(2008).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-228; THR-309; SER-329;
RP   SER-388 AND THR-710, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-309 AND SER-316, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [21]
RP   REVIEW.
RX   PubMed=20350291; DOI=10.1042/BJ20091302;
RA   Newton P.M., Messing R.O.;
RT   "The substrates and binding partners of protein kinase Cepsilon.";
RL   Biochem. J. 427:189-196(2010).
RN   [22]
RP   INTERACTION WITH HSP90AB1.
RX   PubMed=20353823; DOI=10.1016/j.cellsig.2010.03.012;
RA   Cheng M.B., Zhang Y., Zhong X., Sutter B., Cao C.Y., Chen X.S.,
RA   Cheng X.K., Zhang Y., Xiao L., Shen Y.F.;
RT   "Stat1 mediates an auto-regulation of hsp90beta gene in heat shock
RT   response.";
RL   Cell. Signal. 22:1206-1213(2010).
RN   [23]
RP   REVIEW ON FUNCTION IN NEURONS.
RX   PubMed=21681677; DOI=10.1007/s11684-011-0119-9;
RA   Chen Y., Tian Q.;
RT   "The role of protein kinase C epsilon in neural signal transduction
RT   and neurogenic diseases.";
RL   Front. Med. 5:70-76(2011).
RN   [24]
RP   REVIEW.
RX   PubMed=21810427; DOI=10.1016/j.yjmcc.2011.07.013;
RA   Duquesnes N., Lezoualc'h F., Crozatier B.;
RT   "PKC-delta and PKC-epsilon: Foes of the same family or strangers?";
RL   J. Mol. Cell. Cardiol. 51:665-673(2011).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-368, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [26]
RP   X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS) OF 342-372, AND PHOSPHORYLATION
RP   AT SER-346 AND SER-368.
RX   PubMed=19662078; DOI=10.1038/embor.2009.150;
RA   Kostelecky B., Saurin A.T., Purkiss A., Parker P.J., McDonald N.Q.;
RT   "Recognition of an intra-chain tandem 14-3-3 binding site within
RT   PKCepsilon.";
RL   EMBO Rep. 10:983-989(2009).
RN   [27]
RP   VARIANT [LARGE SCALE ANALYSIS] LYS-143.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [28]
RP   VARIANTS [LARGE SCALE ANALYSIS] VAL-333; ARG-389 AND MET-563.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Calcium-independent, phospholipid- and diacylglycerol
CC       (DAG)-dependent serine/threonine-protein kinase that plays
CC       essential roles in the regulation of multiple cellular processes
CC       linked to cytoskeletal proteins, such as cell adhesion, motility,
CC       migration and cell cycle, functions in neuron growth and ion
CC       channel regulation, and is involved in immune response, cancer
CC       cell invasion and regulation of apoptosis. Mediates cell adhesion
CC       to the extracellular matrix via integrin-dependent signaling, by
CC       mediating angiotensin-2-induced activation of integrin beta-1
CC       (ITGB1) in cardiac fibroblasts. Phosphorylates MARCKS, which
CC       phosphorylates and activates PTK2/FAK, leading to the spread of
CC       cardiomyocytes. Involved in the control of the directional
CC       transport of ITGB1 in mesenchymal cells by phosphorylating
CC       vimentin (VIM), an intermediate filament (IF) protein. In
CC       epithelial cells, associates with and phosphorylates keratin-8
CC       (KRT8), which induces targeting of desmoplakin at desmosomes and
CC       regulates cell-cell contact. Phosphorylates IQGAP1, which binds to
CC       CDC42, mediating epithelial cell-cell detachment prior to
CC       migration. In HeLa cells, contributes to hepatocyte growth factor
CC       (HGF)-induced cell migration, and in human corneal epithelial
CC       cells, plays a critical role in wound healing after activation by
CC       HGF. During cytokinesis, forms a complex with YWHAB, which is
CC       crucial for daughter cell separation, and facilitates abscission
CC       by a mechanism which may implicate the regulation of RHOA. In
CC       cardiac myocytes, regulates myofilament function and excitation
CC       coupling at the Z-lines, where it is indirectly associated with F-
CC       actin via interaction with COPB1. During endothelin-induced
CC       cardiomyocyte hypertrophy, mediates activation of PTK2/FAK, which
CC       is critical for cardiomyocyte survival and regulation of sarcomere
CC       length. Plays a role in the pathogenesis of dilated cardiomyopathy
CC       via persistent phosphorylation of troponin I (TNNI3). Involved in
CC       nerve growth factor (NFG)-induced neurite outgrowth and neuron
CC       morphological change independently of its kinase activity, by
CC       inhibition of RHOA pathway, activation of CDC42 and cytoskeletal
CC       rearrangement. May be involved in presynaptic facilitation by
CC       mediating phorbol ester-induced synaptic potentiation.
CC       Phosphorylates gamma-aminobutyric acid receptor subunit gamma-2
CC       (GABRG2), which reduces the response of GABA receptors to ethanol
CC       and benzodiazepines and may mediate acute tolerance to the
CC       intoxicating effects of ethanol. Upon PMA treatment,
CC       phosphorylates the capsaicin- and heat-activated cation channel
CC       TRPV1, which is required for bradykinin-induced sensitization of
CC       the heat response in nociceptive neurons. Is able to form a
CC       complex with PDLIM5 and N-type calcium channel, and may enhance
CC       channel activities and potentiates fast synaptic transmission by
CC       phosphorylating the pore-forming alpha subunit CACNA1B (CaV2.2).
CC       In prostate cancer cells, interacts with and phosphorylates STAT3,
CC       which increases DNA-binding and transcriptional activity of STAT3
CC       and seems to be essential for prostate cancer cell invasion.
CC       Downstream of TLR4, plays an important role in the
CC       lipopolysaccharide (LPS)-induced immune response by
CC       phosphorylating and activating TICAM2/TRAM, which in turn
CC       activates the transcription factor IRF3 and subsequent cytokines
CC       production. In differentiating erythroid progenitors, is regulated
CC       by EPO and controls the protection against the TNFSF10/TRAIL-
CC       mediated apoptosis, via BCL2. May be involved in the regulation of
CC       the insulin-induced phosphorylation and activation of AKT1.
CC       {ECO:0000269|PubMed:11884385, ECO:0000269|PubMed:1374067,
CC       ECO:0000269|PubMed:15355962, ECO:0000269|PubMed:16757566,
CC       ECO:0000269|PubMed:17603037, ECO:0000269|PubMed:17875639,
CC       ECO:0000269|PubMed:17875724}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Novel PKCs (PRKCD, PRKCE, PRKCH and PRKCQ) are
CC       calcium-insensitive, but activated by diacylglycerol (DAG) and
CC       phosphatidylserine. Three specific sites; Thr-566 (activation loop
CC       of the kinase domain), Thr-710 (turn motif) and Ser-729
CC       (hydrophobic region), need to be phosphorylated for its full
CC       activation.
CC   -!- SUBUNIT: Forms a ternary complex with TRIM63 and GN2BL1. Can form
CC       a complex with PDLIM5 and N-type calcium channel. Interacts with
CC       COPB1 and YWHAB (By similarity). Interacts with DGKQ and STAT3.
CC       Interacts with HSP90AB1; promotes functional activation in a heat
CC       shock-dependent manner (PubMed:20353823). {ECO:0000250,
CC       ECO:0000269|PubMed:15632189, ECO:0000269|PubMed:17875724,
CC       ECO:0000269|PubMed:20353823}.
CC   -!- INTERACTION:
CC       P08238:HSP90AB1; NbExp=2; IntAct=EBI-706254, EBI-352572;
CC       C6GKH1:IL32; NbExp=2; IntAct=EBI-706254, EBI-9547476;
CC       Q15349:RPS6KA2; NbExp=2; IntAct=EBI-706254, EBI-1384149;
CC       P63104:YWHAZ; NbExp=5; IntAct=EBI-706254, EBI-347088;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17603037}.
CC       Cytoplasm, cytoskeleton {ECO:0000269|PubMed:17603037}. Cell
CC       membrane {ECO:0000269|PubMed:17603037}. Cytoplasm, perinuclear
CC       region {ECO:0000250}. Nucleus {ECO:0000250}. Note=Translocated to
CC       plasma membrane in epithelial cells stimulated by HGF. Associated
CC       with the Golgi at the perinuclear site in pre-passage fibroblasts
CC       (By similarity). In passaging cells, translocated to the cell
CC       periphery (By similarity). Translocated to the nucleus in PMA-
CC       treated cells (By similarity). {ECO:0000250}.
CC   -!- DOMAIN: The C1 domain, containing the phorbol ester/DAG-type
CC       region 1 (C1A) and 2 (C1B), is the diacylglycerol sensor and the
CC       C2 domain is a non-calcium binding domain.
CC   -!- PTM: Phosphorylation on Thr-566 by PDPK1 triggers
CC       autophosphorylation on Ser-729. Phosphorylation in the hinge
CC       domain at Ser-350 by MAPK11 or MAPK14, Ser-346 by GSK3B and Ser-
CC       368 by autophosphorylation is required for interaction with YWHAB.
CC       {ECO:0000269|PubMed:11964154, ECO:0000269|PubMed:19662078}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. PKC subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X65293; CAA46388.1; -; mRNA.
DR   EMBL; EU332867; ABY87556.1; -; Genomic_DNA.
DR   EMBL; U51244; AAD08855.1; -; Genomic_DNA.
DR   EMBL; AC017078; AAY14773.1; -; Genomic_DNA.
DR   EMBL; AC017006; AAX93253.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAX00258.1; -; Genomic_DNA.
DR   EMBL; BC109033; AAI09034.1; -; mRNA.
DR   EMBL; BC109034; AAI09035.1; -; mRNA.
DR   CCDS; CCDS1824.1; -.
DR   PIR; S28942; S28942.
DR   RefSeq; NP_005391.1; NM_005400.2.
DR   RefSeq; XP_005264485.1; XM_005264428.1.
DR   UniGene; Hs.580351; -.
DR   UniGene; Hs.677120; -.
DR   PDB; 2WH0; X-ray; 2.25 A; Q/R=342-372.
DR   PDB; 5LIH; X-ray; 3.25 A; F/G=149-164.
DR   PDBsum; 2WH0; -.
DR   PDBsum; 5LIH; -.
DR   ProteinModelPortal; Q02156; -.
DR   SMR; Q02156; -.
DR   BioGrid; 111567; 52.
DR   DIP; DIP-34186N; -.
DR   IntAct; Q02156; 13.
DR   MINT; MINT-88515; -.
DR   STRING; 9606.ENSP00000306124; -.
DR   BindingDB; Q02156; -.
DR   ChEMBL; CHEMBL3582; -.
DR   DrugBank; DB06064; KAI-1455.
DR   DrugBank; DB00675; Tamoxifen.
DR   GuidetoPHARMACOLOGY; 1486; -.
DR   iPTMnet; Q02156; -.
DR   PhosphoSitePlus; Q02156; -.
DR   BioMuta; PRKCE; -.
DR   DMDM; 400135; -.
DR   EPD; Q02156; -.
DR   MaxQB; Q02156; -.
DR   PaxDb; Q02156; -.
DR   PeptideAtlas; Q02156; -.
DR   PRIDE; Q02156; -.
DR   DNASU; 5581; -.
DR   Ensembl; ENST00000306156; ENSP00000306124; ENSG00000171132.
DR   GeneID; 5581; -.
DR   KEGG; hsa:5581; -.
DR   UCSC; uc002rut.4; human.
DR   CTD; 5581; -.
DR   DisGeNET; 5581; -.
DR   GeneCards; PRKCE; -.
DR   HGNC; HGNC:9401; PRKCE.
DR   HPA; CAB001948; -.
DR   HPA; HPA044496; -.
DR   HPA; HPA054252; -.
DR   MIM; 176975; gene.
DR   neXtProt; NX_Q02156; -.
DR   OpenTargets; ENSG00000171132; -.
DR   PharmGKB; PA33765; -.
DR   eggNOG; KOG0694; Eukaryota.
DR   eggNOG; ENOG410XNPH; LUCA.
DR   GeneTree; ENSGT00820000126964; -.
DR   HOGENOM; HOG000233022; -.
DR   HOVERGEN; HBG108317; -.
DR   InParanoid; Q02156; -.
DR   KO; K18050; -.
DR   OMA; DEDVDCT; -.
DR   OrthoDB; EOG091G0QRS; -.
DR   PhylomeDB; Q02156; -.
DR   TreeFam; TF351133; -.
DR   BRENDA; 2.7.11.13; 2681.
DR   Reactome; R-HSA-114508; Effects of PIP2 hydrolysis.
DR   Reactome; R-HSA-1250196; SHC1 events in ERBB2 signaling.
DR   Reactome; R-HSA-1489509; DAG and IP3 signaling.
DR   Reactome; R-HSA-2029485; Role of phospholipids in phagocytosis.
DR   Reactome; R-HSA-418597; G alpha (z) signalling events.
DR   SABIO-RK; Q02156; -.
DR   SignaLink; Q02156; -.
DR   SIGNOR; Q02156; -.
DR   ChiTaRS; PRKCE; human.
DR   EvolutionaryTrace; Q02156; -.
DR   GeneWiki; PRKCE; -.
DR   GenomeRNAi; 5581; -.
DR   PMAP-CutDB; Q02156; -.
DR   PRO; PR:Q02156; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000171132; -.
DR   CleanEx; HS_PRKCE; -.
DR   ExpressionAtlas; Q02156; baseline and differential.
DR   Genevisible; Q02156; HS.
DR   GO; GO:0071944; C:cell periphery; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:BHF-UCL.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:Ensembl.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0071889; F:14-3-3 protein binding; IEA:Ensembl.
DR   GO; GO:0003785; F:actin monomer binding; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004699; F:calcium-independent protein kinase C activity; IEA:Ensembl.
DR   GO; GO:0008047; F:enzyme activator activity; IMP:BHF-UCL.
DR   GO; GO:0019899; F:enzyme binding; IDA:BHF-UCL.
DR   GO; GO:0035276; F:ethanol binding; IEA:Ensembl.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004697; F:protein kinase C activity; IDA:BHF-UCL.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0030546; F:receptor activator activity; IEA:Ensembl.
DR   GO; GO:0004871; F:signal transducer activity; TAS:ProtInc.
DR   GO; GO:0007202; P:activation of phospholipase C activity; TAS:Reactome.
DR   GO; GO:0006915; P:apoptotic process; TAS:ProtInc.
DR   GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0071361; P:cellular response to ethanol; IEA:Ensembl.
DR   GO; GO:0071456; P:cellular response to hypoxia; IEA:Ensembl.
DR   GO; GO:0071380; P:cellular response to prostaglandin E stimulus; IEA:Ensembl.
DR   GO; GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0031663; P:lipopolysaccharide-mediated signaling pathway; ISS:UniProtKB.
DR   GO; GO:0035641; P:locomotory exploration behavior; IEA:Ensembl.
DR   GO; GO:0002281; P:macrophage activation involved in immune response; IEA:Ensembl.
DR   GO; GO:0031397; P:negative regulation of protein ubiquitination; IEA:Ensembl.
DR   GO; GO:2000650; P:negative regulation of sodium ion transmembrane transporter activity; TAS:BHF-UCL.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IDA:UniProtKB.
DR   GO; GO:0030168; P:platelet activation; TAS:Reactome.
DR   GO; GO:0030838; P:positive regulation of actin filament polymerization; ISS:UniProtKB.
DR   GO; GO:0010811; P:positive regulation of cell-substrate adhesion; IEA:Ensembl.
DR   GO; GO:2001031; P:positive regulation of cellular glucuronidation; IMP:BHF-UCL.
DR   GO; GO:0032467; P:positive regulation of cytokinesis; IMP:UniProtKB.
DR   GO; GO:0010634; P:positive regulation of epithelial cell migration; IMP:UniProtKB.
DR   GO; GO:0010763; P:positive regulation of fibroblast migration; ISS:UniProtKB.
DR   GO; GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEA:Ensembl.
DR   GO; GO:0032024; P:positive regulation of insulin secretion; IEA:Ensembl.
DR   GO; GO:0050996; P:positive regulation of lipid catabolic process; IEA:Ensembl.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; IEA:Ensembl.
DR   GO; GO:0070257; P:positive regulation of mucus secretion; IEA:Ensembl.
DR   GO; GO:1903078; P:positive regulation of protein localization to plasma membrane; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0032230; P:positive regulation of synaptic transmission, GABAergic; IEA:Ensembl.
DR   GO; GO:0090303; P:positive regulation of wound healing; IMP:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:BHF-UCL.
DR   GO; GO:0061178; P:regulation of insulin secretion involved in cellular response to glucose stimulus; IEA:Ensembl.
DR   GO; GO:0050730; P:regulation of peptidyl-tyrosine phosphorylation; IEA:Ensembl.
DR   GO; GO:0051279; P:regulation of release of sequestered calcium ion into cytosol; IEA:Ensembl.
DR   GO; GO:0051209; P:release of sequestered calcium ion into cytosol; IEA:Ensembl.
DR   GO; GO:0043278; P:response to morphine; IEA:Ensembl.
DR   GO; GO:0007165; P:signal transduction; TAS:Reactome.
DR   GO; GO:0035669; P:TRAM-dependent toll-like receptor 4 signaling pathway; ISS:UniProtKB.
DR   CDD; cd00029; C1; 2.
DR   CDD; cd05591; STKc_nPKC_epsilon; 1.
DR   Gene3D; 2.60.40.150; -; 1.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR020454; DAG/PE-bd.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR034669; nPKC_epsilon.
DR   InterPro; IPR002219; PE/DAG-bd.
DR   InterPro; IPR027274; PKC_epsilon.
DR   InterPro; IPR017892; Pkinase_C.
DR   InterPro; IPR014376; Prot_kin_PKC_delta.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00130; C1_1; 2.
DR   Pfam; PF00168; C2; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00433; Pkinase_C; 1.
DR   PIRSF; PIRSF000551; PKC_delta; 1.
DR   PIRSF; PIRSF501106; Protein_kin_C_epsilon; 1.
DR   PRINTS; PR00008; DAGPEDOMAIN.
DR   SMART; SM00109; C1; 2.
DR   SMART; SM00239; C2; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF49562; SSF49562; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS50004; C2; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 2.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Cell adhesion; Cell cycle; Cell division;
KW   Cell membrane; Complete proteome; Cytoplasm; Cytoskeleton; Immunity;
KW   Kinase; Membrane; Metal-binding; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repeat;
KW   Serine/threonine-protein kinase; Transferase; Zinc; Zinc-finger.
FT   CHAIN         1    737       Protein kinase C epsilon type.
FT                                /FTId=PRO_0000055697.
FT   DOMAIN        1     99       C2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00041}.
FT   DOMAIN      408    668       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   DOMAIN      669    737       AGC-kinase C-terminal.
FT   ZN_FING     169    220       Phorbol-ester/DAG-type 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00226}.
FT   ZN_FING     242    292       Phorbol-ester/DAG-type 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00226}.
FT   NP_BIND     414    422       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOTIF       223    228       Interaction with actin. {ECO:0000250}.
FT   ACT_SITE    532    532       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING     437    437       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES      62     62       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P16054}.
FT   MOD_RES     228    228       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18691976}.
FT   MOD_RES     234    234       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P16054}.
FT   MOD_RES     309    309       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976}.
FT   MOD_RES     316    316       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     329    329       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976}.
FT   MOD_RES     337    337       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P16054}.
FT   MOD_RES     346    346       Phosphoserine; by GSK3-beta.
FT                                {ECO:0000305|PubMed:19662078}.
FT   MOD_RES     349    349       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P16054}.
FT   MOD_RES     350    350       Phosphoserine; by MAPK11 and MAPK14.
FT                                {ECO:0000305}.
FT   MOD_RES     368    368       Phosphoserine; by autocatalysis.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000305|PubMed:19662078}.
FT   MOD_RES     388    388       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976}.
FT   MOD_RES     566    566       Phosphothreonine; by PDPK1.
FT                                {ECO:0000269|PubMed:11964154}.
FT   MOD_RES     703    703       Phosphothreonine; by autocatalysis.
FT                                {ECO:0000255}.
FT   MOD_RES     710    710       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18691976}.
FT   MOD_RES     729    729       Phosphoserine; by autocatalysis.
FT                                {ECO:0000269|PubMed:11964154}.
FT   VARIANT     143    143       E -> K (in a colorectal cancer sample;
FT                                somatic mutation; dbSNP:rs772834505).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035466.
FT   VARIANT     333    333       A -> V (in dbSNP:rs55989965).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042307.
FT   VARIANT     389    389       P -> R (in dbSNP:rs55767130).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042308.
FT   VARIANT     563    563       T -> M (in dbSNP:rs34077350).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042309.
FT   VARIANT     654    654       A -> T (in dbSNP:rs35777875).
FT                                /FTId=VAR_050559.
FT   MUTAGEN     437    437       K->W: Abolishes activity and S-729
FT                                phosphorylation.
FT                                {ECO:0000269|PubMed:11964154}.
FT   MUTAGEN     566    566       T->A: Abolishes phosphorylation by PDK1,
FT                                and S-729 phosphorylation.
FT                                {ECO:0000269|PubMed:11964154}.
FT   MUTAGEN     566    566       T->E: No effect on S-729 phosphorylation.
FT                                {ECO:0000269|PubMed:11964154}.
FT   MUTAGEN     710    710       T->E: No effect on activity; no effect on
FT                                S-729 phosphorylation.
FT                                {ECO:0000269|PubMed:11964154}.
FT   MUTAGEN     729    729       S->A: Enhances T-566 dephosphorylation.
FT                                {ECO:0000269|PubMed:11964154}.
SQ   SEQUENCE   737 AA;  83674 MW;  85032D0A091A1F7F CRC64;
     MVVFNGLLKI KICEAVSLKP TAWSLRHAVG PRPQTFLLDP YIALNVDDSR IGQTATKQKT
     NSPAWHDEFV TDVCNGRKIE LAVFHDAPIG YDDFVANCTI QFEELLQNGS RHFEDWIDLE
     PEGRVYVIID LSGSSGEAPK DNEERVFRER MRPRKRQGAV RRRVHQVNGH KFMATYLRQP
     TYCSHCRDFI WGVIGKQGYQ CQVCTCVVHK RCHELIITKC AGLKKQETPD QVGSQRFSVN
     MPHKFGIHNY KVPTFCDHCG SLLWGLLRQG LQCKVCKMNV HRRCETNVAP NCGVDARGIA
     KVLADLGVTP DKITNSGQRR KKLIAGAESP QPASGSSPSE EDRSKSAPTS PCDQEIKELE
     NNIRKALSFD NRGEEHRAAS SPDGQLMSPG ENGEVRQGQA KRLGLDEFNF IKVLGKGSFG
     KVMLAELKGK DEVYAVKVLK KDVILQDDDV DCTMTEKRIL ALARKHPYLT QLYCCFQTKD
     RLFFVMEYVN GGDLMFQIQR SRKFDEPRSR FYAAEVTSAL MFLHQHGVIY RDLKLDNILL
     DAEGHCKLAD FGMCKEGILN GVTTTTFCGT PDYIAPEILQ ELEYGPSVDW WALGVLMYEM
     MAGQPPFEAD NEDDLFESIL HDDVLYPVWL SKEAVSILKA FMTKNPHKRL GCVASQNGED
     AIKQHPFFKE IDWVLLEQKK IKPPFKPRIK TKRDVNNFDQ DFTREEPVLT LVDEAIVKQI
     NQEEFKGFSY FGEDLMP
//
